Metaplastic breast carcinoma: clinicopathologic features and prognostic value of triple negativity (Q43249133)

17 November 2017

title

Metaplastic breast carcinoma: clinicopathologic features and prognostic value of triple negativity (English)

1 reference

17 November 2017

1 reference

Dong-Young Noh

1 reference

17 November 2017

Eui Kyu Chie

1 reference

17 November 2017

Yung-Jue Bang

1 reference

17 November 2017

Seock-Ah Im

1 reference

17 November 2017

Do-Youn Oh

1 reference

17 November 2017

Tae-You Kim

1 reference

17 November 2017

Wonshik Han

1 reference

17 November 2017

Kyu-Hyoung Lim

1 reference

17 November 2017

In Ae Park

1 reference

17 November 2017

Sung Whan Ha

series ordinal

1 reference

17 November 2017

publication date

3 November 2009

1 reference

Japanese Journal of Clinical Oncology

17 November 2017

published in

1 reference

17 November 2017

1 reference

17 November 2017

1 reference

17 November 2017

page(s)

112-118

1 reference

Metaplastic carcinomas of the breast. II. Spindle cell carcinoma

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP139

Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP139

Metaplastic carcinomas of the breast: V. Metaplastic carcinoma with osteoclastic giant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP139

Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP139

Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP139

Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP139

Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP139

Spindle cell carcinoma of the breast: a case series of a rare histological subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP139

Updated recommendations from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP139

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP139

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP139

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP139

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP139

Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP139

21 January 2018

Identifiers

DOI

10.1093/JJCO/HYP139

1 reference

17 November 2017

1 reference